The assessment of lesion detection capability and FDG uptake value by digital PET/CT

The assessment of lesion detection capability and FDG uptake value by digital PET/CT - The assessment of lesion detection capability and FDG uptake value by digital PET/CT

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000040015

Enrollment

200

Registered

2020-04-01

Start date

2020-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignancy, vasculitis, cardiac sarcoidosis, etc.

Interventions

Patients receive an intravenous administration of FDG as in the usual PET scan. Patients undergo the digital PET/CT scan (Discovery Mi-AM edition, GE Healthcare) and the analog PET scan (Discovery

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who obtained written consent before PET/CT.

Exclusion criteria

Exclusion criteria: 1) Patients who have difficulty remaining still during PET/CT scan. 2) Patients who have undergone multiple PET/CT scans by the same imaging protocol during the study period and have already been included in this study. 3) Other patients who are judged to be unsuitable for this study by the study physician.

Design outcomes

Primary

Measure	Time frame
Lesion detection capability	—

Secondary

Measure	Time frame
SUVmax of the lesions and Physiological Accumulation,image quality	—

Countries

Japan

Contacts

Public ContactNaoto Kawaguchi

Ehime University graduate school of medicine Department of radiology

n.kawa1113@gmail.com089-964-5111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026